RobertEnochLitmanMD

Psychiatry • Rockville, MD

Geriatric Psychiatry

Associate Professor, Psychiatry, Georgetown University School of Medicine

Join to view full profile

Dr. Litman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Litman's full profile

Already have an account?

Office
9605 Medical Center Dr
Suite 270
Rockville, MD 20850
Phone+1 301-251-4702

Fax+1 301-762-5711
Is this information wrong?

Education & Training

National Institutes of Health Clinical CenterResidency, Psychiatry, 1988 - 1989
Massachusetts General Hospital/McLean HospitalResidency, Psychiatry, 1981 - 1984
Albany Medical CenterInternship, Internal Medicine, 1980 - 1981
Albany Medical CollegeClass of 1980

Certifications & Licensure

MD State Medical License 1987 - 2024
DC State Medical License 1989 - 2014
VA State Medical License 2004 - 2008
American Board of Psychiatry and Neurology Psychiatry

Clinical Trials

PEARL Schizophrenia Maintenance Start of enrollment: 2011 Sep 01
Completed
Phase 3
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia Start of enrollment: 2014 Mar 26
Completed
Phase 2
Bioavailability of LY03004 and Risperdal® Consta® Start of enrollment: 2014 Sep 01
Completed
Phase 1
Study to Determine the Safety, Tolerability, and Efficacy of Evenamide in Patients With Chronic Schizophrenia Start of enrollment: 2020 Jun 16
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

Impact of COVID-19 Pandemic on Patients with Serious Mental Illness (SMI) and Nonpsychiatric Control Subjects in Clinical Trials.
Maria Fe Garcia-Rada, Robert E Litman> ;Innovations in Clinical Neuroscience. 2024 Mar 1
12 citations
The D-amino acid oxidase inhibitor luvadaxistat improves mismatch negativity in patients with schizophrenia in a randomized trial.
Patricio O'Donnell, Cheng Dong, Venkatesha Murthy, Mahnaz Asgharnejad, Xiaoming Du, Ann Summerfelt, Hong Lu, Lin Xu, Jens R Wendland, Eduardo Dunayevich, Derek L Buhl,...> ;Neuropsychopharmacology. 2023 Jun 1
Impact of COVID-19 Pandemic on Psychiatric Patients at Clinical Trial Sites.
Maria Fe Garcia-Rada, Robert E Litman> ;Innovations in Clinical Neuroscience. 2023 Jan 2
1 citations
Personal and Social Functioning and Health-Related Quality of Life in Patients with Schizophrenia Treated with the Long-Acting Injectable Antipsychotic Risperidone ISM.
Robert Litman, Dieter Naber, Lourdes Anta, Javier Martínez, Yuriy Filts, Christoph U Correll> ;Neuropsychiatric Disease and Treatment. 2023 Jan 1
Corrigendum to "Long-term efficacy and safety of once-monthly Risperidone ISM® in the treatment of schizophrenia: Results from a 12-month open-label extension study" [...
Yuriy Filts, Robert E Litman, Javier Martínez, Lourdes Anta, Dieter Naber, Christoph U Correll> ;Schizophrenia Research. 2022 Aug 1
5 citations
Long-term efficacy and safety of once-monthly Risperidone ISM® in the treatment of schizophrenia: Results from a 12-month open-label extension study
Yuriy Filts, Robert E. Litman, Javier Martínez, Lourdes Anta, Dieter Naber, Christoph U. Correll> ;Schizophrenia Research. 2022 Jan 1
Drug Development for Mental Illness: How Psychiatry Clinical Trial Sites are Meeting the Challenge of the COVID-19 Pandemic
Robert E. Litman, Peter Sorantin, Elia E Acevedo-Diaz> ;Innovations in Clinical Neuroscience. 2021 Jan 1
11 citations
Efficacy and safety of once-monthly Risperidone ISM ® in schizophrenic patients with an acute exacerbation.
Christoph U. Correll, Robert E. Litman, Yuriy Filts, Jordi Llaudó, Dieter Naber, Ferran Torres, Javier Martínez> ;NPJ Schizophrenia. 2020 Nov 25
12 citations
Herpes simplex virus 1 infection and valacyclovir treatment in schizophrenia: Results from the VISTA study.
Alan Breier, Robert W. Buchanan, Deepak Cyril D'Souza, Keith H. Nuechterlein, Stephen R. Marder, Walter Dunn, Sheldon H. Preskorn, Matthew Macaluso, Brent E. Wurfel, G...> ;Schizophrenia Research. 2019 Apr 1
40 citations
Dopamine D2 receptor occupancy of lumateperone (ITI-007): a Positron Emission Tomography Study in patients with schizophrenia.
Kimberly E. Vanover, Robert E. Davis, Yun Zhou, Weiguo Ye, James Robert Brašić, Lorena Gapasin, Jelena Saillard, Michal Weingart, Robert E. Litman, Sharon Mates, Dean ...> ;Neuropsychopharmacology. 2019 Feb 1
7 citations
Global improvement with cariprazine in the treatment of bipolar I disorder and schizophrenia: A pooled post hoc analysis.
Suresh Durgam, Willie Earley, Kaifeng Lu, György Németh, István Laszlovszky, Stephen Volk, Robert E. Litman> ;International Journal of Clinical Practice. 2017 Nov 9
11 citations
A phase II study to evaluate the pharmacokinetics, safety, and tolerability of Risperidone ISM multiple intramuscular injections once every 4 weeks in patients with sc...
Lourdes A. Carabias, Jordi Llaudó, Ignacio Ayani, Javier Martínez, Robert E. Litman, Ibon Gutierro> ;International Clinical Psychopharmacology. 2017 Nov 1
61 citations
AZD8529, a positive allosteric modulator at the mGluR2 receptor, does not improve symptoms in schizophrenia: A proof of principle study.
Robert E. Litman, Mark A. Smith, James J. Doherty, Alan J. Cross, Shane Raines, Lev Gertsik, Stephen R. Zukin> ;Schizophrenia Research. 2014 Apr 1
47 citations
Cariprazine in the treatment of schizophrenia: a proof-of-concept trial
Suresh Durgam, Robert E. Litman, Kelly Papadakis, Dayong Li, György Németh, István Laszlovszky> ;International Clinical Psychopharmacology. 2016 Mar 1
26 citations
The selective neurokinin 3 antagonist AZD2624 does not improve symptoms or cognition in schizophrenia: a proof-of-principle study.
Robert E. Litman, Mark A. Smith, Dhaval G. Desai, Thomas Simpson, Dennis Sweitzer, Stephen J. Kanes> ;Journal of Clinical Psychopharmacology. 2014 Apr 1
128 citations
Paliperidone palmitate, a potential long-acting treatment for patients with schizophrenia. Results of a randomized, double-blind, placebo-controlled efficacy and safet...
Michelle Kramer, Robert E. Litman, David Hough, Rosanne Lane, Pilar Lim, Yanning Liu, Mariëlle Eerdekens> ;The International Journal of Neuropsychopharmacology. 2010 Jun 1
108 citations
A randomized, placebo-controlled study of memantine as adjunctive treatment in patients with schizophrenia.
Jeffrey A. Lieberman, Kelly Papadakis, John G. Csernansky, Robert E. Litman, Jan Volavka, Xinwei Daniel Jia, Allyson Gage> ;Neuropsychopharmacology. 2009 Apr 1
56 citations
Efficacy of iloperidone in the treatment of schizophrenia: initial phase 3 studies.
Steven G. Potkin, Robert E. Litman, Rosarelis Torres, Curt D. Wolfgang> ;Journal of Clinical Psychopharmacology. 2008 Apr 1
21 citations
A quantitative analysis of smooth pursuit eye tracking in monozygotic twins discordant for schizophrenia.
Robert E. Litman, E. Fuller Torrey, Daniel W. Hommer, Allan R. Radant, David Pickar, Daniel R. Weinberger> ;Archives of General Psychiatry. 1997 May 1
55 citations
The Brain Metabolic Patterns of Clozapine- and Fluphenazine-Treated Patients With Schizophrenia During a Continuous Performance Task
Robert M. Cohen, Thomas E. Nordahl, William E. Semple, Paul J. Andreason, Robert E. Litman, David Pickar> ;Archives of General Psychiatry. 1997 May 1
101 citations
Idazoxan and response to typical neuroleptics in treatment-resistant schizophrenia. Comparison with the atypical neuroleptic, clozapine.
Robert E. Litman, Tung Ping Su, William Z. Potter, Walter W. Hong, David Pickar> ;The British Journal of Psychiatry. 1996 May 1
11 citations
A : ALGORITHMS FOR THE TREATMENT OF SCHIZOPHRENIA
Zarate Ca, Daniel Dg, Bruce J. Kinon, Robert E. Litman, Naber D, David Pickar, Sato M> ;Psychopharmacology Bulletin. 1995 Jan 1
43 citations
Quantitative effects of typical and atypical neuroleptics on smooth pursuit eye tracking in schizophrenia
Robert E. Litman, Daniel W. Hommer, Allen D. Radant, Thomas Clem, David Pickar> ;Schizophrenia Research. 1994 May 1
10 citations
Clinical Response to Clozapine in Patients With Schizophrenia
David Pickar, Robert E. Litman, Walter W. Hong, T.-P. Su, Ellen M. Weissman, John K. Hsiao, William Z. Potter> ;Archives of General Psychiatry. 1994 Feb 1
34 citations
Adverse effects of antipsychotic drugs
Anil K. Malhotra, Robert E. Litman, David Pickar> ;Drug Safety. 1993 Dec 1
Join now to see all

Journal Articles

Dopamine D2 Receptor Occupancy of Lumateperone (ITI-007): A Positron Emission Tomography Study in Patients with Schizophrenia
Robert E Litman, Dean F Wong, James R Brasic, Nature

Hospital Affiliations

Adventist Healthcare Shady Grove Medical CenterRockville, Maryland